SPA17 and pulmonary fibrosis: Additionally, linear regression data demonstrated that SPA17 expression was negatively correlated with FVC‐pre, FVC‐pro, and DLCO, suggesting that elevated SPA17 levels may be linked to worse clinical outcomes in pulmonary fibrosis patients (Figure 7A–E).